From: T2 mapping of molecular subtypes of WHO grade II/III gliomas
IDH-mut (n = 18) | IDH-wt (n = 12) | p-value* | |
---|---|---|---|
age, yr. (mean, range) | 41,32 ± 12,3 [28–74] | 55,69 ± 16,39 [34–81] | 0,0105 |
A2 | 38,13 ± 11,53 [28–57] | 64,22 ± 18,25 [41–81] | |
AA3 | 42,55 ± 12,81 [29–74] | 51,42 ± 14,73 [34–74] | |
sex (no.) | n = 18 | n = 12 | < 0,0001 |
female | 9 (50%) | 1 (8,33%) | |
male | 9 (50%) | 11 (91,67%) | |
tumor grade | n = 18 | n = 12 | |
A2 | 5 (27,78%) | 4 (33,33%) | |
AA3 | 13 (72,22%) | 8 (66,67%) | |
tumor localization | n = 18 | n = 12 | < 0,0001** |
fronto-parietal | frontal (38,89%) parietal (16,67%) frontoparietal (11,1%) | frontal (16,67%) parietal (16,67%) | |
other | fronto-parieto-temporal (16,67%) temporal (11,1%) parieto-temporal (5,56%) | thalamic (25%) temporal (16,67%) frontotemporal (8,33%) corpus callosum (8,33%) 5 single lesions (8,33%) |